HUMAN HEALTH(01419): Chen Xiwen appointed as independent non-executive director
Yingjiann Medical (01419) announced that Chen Xiwen was appointed as an independent non-executive director, effective from October 1, 2024...
HUMAN HEALTH (01419) announced that Chen Xiwen has been appointed as an independent non-executive director, effective from October 1, 2024.
Simon Sin Ka-tim will retire and will not participate in the re-election at the shareholders' annual general meeting.
After the retirement of Simon Sin Ka-tim on October 1, 2024, the composition of the Company's Board of Directors will be changed as follows: Chen Xiwen will be appointed as a member of the Audit Committee, Remuneration Committee, and Nomination Committee starting from October 1, 2024; and after the conclusion of the shareholders' annual general meeting, Chen Xiwen will be appointed as the Chairman of the Audit Committee, subject to re-election by shareholders as an independent non-executive director at the shareholders' annual general meeting.
Related Articles

HK Stock Market Move | INSILICO (03696) rises more than 6% against the market trend. The Phase III clinical conference of Rentosertib is held, verifying the AI research and development capabilities once again.

HK Stock Market Move | NIO-SW(09866) rose over 6%, ES9 will welcome 10,000 deliveries this month, and the company's product portfolio continues to expand.

HK Stock Market Move | ZAI LAB(09688) rose more than 7% against the market recently. Zoci was recently granted orphan drug designation by the European Medicines Agency.
HK Stock Market Move | INSILICO (03696) rises more than 6% against the market trend. The Phase III clinical conference of Rentosertib is held, verifying the AI research and development capabilities once again.

HK Stock Market Move | NIO-SW(09866) rose over 6%, ES9 will welcome 10,000 deliveries this month, and the company's product portfolio continues to expand.

HK Stock Market Move | ZAI LAB(09688) rose more than 7% against the market recently. Zoci was recently granted orphan drug designation by the European Medicines Agency.

RECOMMEND





